Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Use of SPMDs and rainbow trout to examine CYP1A1 induction in creosote contaminated mesocosms

Conference ·
OSTI ID:458374
; ; ; ;  [1];  [2]
  1. Univ. of Waterloo, Ontario (Canada)
  2. Univ. of Guelph, Ontario (Canada). Centre for Toxicology
Lipid-containing semipermeable membrane devices (SPMDs) and rainbow trout (Oncorhynchus mykiss) were exposed to creosote-dosed mesocosms for a 28 day period. Creosote concentration and exposure period were varied and examined for effects on hepatic and cardiac 7-ethoxyresorufin-O-deethylase (EROD) activity in trout. SPMD uptake rates and selectivity for specific polycyclic aromatic hydrocarbons (PAHs) were also studied. Concentrations of PAHs in SPMDs were compared to PAH concentrations determined in tissues of exposed rainbow trout in order to examine effects of metabolism on PAH burden in living systems. In addition, subfractions of SPMD dialysates and rainbow trout tissue extracts were exposed to the RTL-W1 rainbow trout liver cell line and the H4IIE rat hepatoma cell line. These bioassays were used to measure 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent concentrations (TECs) of the liver residues as indicated by their relative abilities to induce cytochrome P4501A1 (CYP1A1), measured as EROD activity. This estimates the accumulation by fish of compounds that act through the Ah receptor and are potentially toxic. Hepatic and cardiac EROD activity in the trout were significantly elevated in ponds dosed with creosote as compared to the control pond (ANOVA, p < 0.05) and rose with increasing creosote concentration.
OSTI ID:
458374
Report Number(s):
CONF-961149--
Country of Publication:
United States
Language:
English